Smart Health Enterprise Model Could Enhance Patient Experiences, Outcomes
Can smart technologies improve the patient experience?
Can smart technologies improve the patient experience?
C100 injections led to synergistic therapeutic effects with anti-PD1 immune checkpoint blockade (ICB) therapy in a preclinical model.
Capsida plans to advance its gene therapy program into clinical development in the first half of 2025.
The integration of blockchain and AI can be promising. Here is how both can complement each other and offer help in every industry.
This Medical News article discusses research initiatives to support produce prescriptions and other “food is medicine” nutrition programs in health care settings.
This could change diagnosis and treatment.
SalioGen’s lipid nanoparticle delivery of bioengineered mammalian transposases can integrate large genes at precise genomic locations.
Protein-truncating variants escaping nonsense-mediated decay (PTVescs) are often overlooked in genetic disease. We examined individuals with neurodevelopmental disorders referred for clinical exome sequencing for gene-level…
KateTx debuted less than a year ago with a $51 million Series A round co-led by Westlake Village BioPartners and Versant Ventures.
Novo Nordisk and Metaphore Biotechnologies will partner to develop obesity management treatments in an up-to-$600 million-plus collaboration.
The Francis Crick Institute is partnering to develop novel applications for Broken String’s DNA break-mapping platform, INDUCE-seq, to investigate the impact of genomic instability in…